Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty.
Noordin S, Waters TS, Garbuz DS, Duncan CP, Masri BA
Clin Orthop Relat Res 2010; Jun 24 [Epub ahead of print].
Review by E. Bisbe
A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J
Anesth Analg 2004;99:262-271.
Review by
An audit on the blood transfusion requirements for revision hip arthroplasty.
Sharma S, Cooper H, Ivory JP
Ann R Coll Surg Engl 2002;84(4):269-272.
Review by Earnshaw P
Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial.
McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R
BMJ 2002;324(7349):1299-1302.
Review by V. Kretschmer
Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty.
Friederichs MG, Mariani EM, Bourne MH
J Arthroplasty 2002;17(3):298-303.
Review by Hansen E
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659